Celltrion, Top Search Ranking... Stock Price -1.71%
As of 11:31 AM on the 19th, Celltrion is trading at 287,000 KRW, down 1.71% from the previous day. This represents a 9.89% decrease compared to February 19. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 23,621 shares of Celltrion, and institutions have net sold 9,000 shares, according to provisional data. Over the past five days, individual investors have net bought 167,391 shares, while foreigners and institutions have net sold 107,283 shares and 62,152 shares, respectively.
On March 17, Celltrion was in the spotlight in the market with the news of a "21 billion KRW scale 'Truxima' supply contract... stock price declining."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
